ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00397293
Recruitment Status : Completed
First Posted : November 9, 2006
Last Update Posted : August 24, 2010
Sponsor:
Information provided by:
Ascenta Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : December 2008
  Certification/Extension First Submitted : August 12, 2010